stockrowSotera Health Company
SHC Healthcare Diagnostics & Research
Sotera Health Company’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 5.74% from fiscal 2024.
- Revenue
- +4.36%
- EPS
- +20.1%
- Free cash flow
- +65.0%
- Total debt
- +0.14%
Quarter to September 2026, against a year earlier
Follow SHC
Alert me
Sotera Health Company (SHC) Gross margin
Sotera Health Company's gross margin over the twelve months to 30 September 2026 was 54.6%, down 0.9 percentage points from fiscal 2025 (55.5%). Over the past ten years it has ranged from 47.9% (fiscal 2018) to 55.7% (fiscal 2021); the current reading is higher than 75% of that period. That is above the Diagnostics & Research industry median of 48.3% and in line with the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 55.5% | 0.75 |
| FY2024 | 54.7% | (0.27) |
| FY2023 | 55.0% | (0.50) |
| FY2022 | 55.5% | (0.18) |
| FY2021 | 55.7% | 1.46 |
| FY2020 | 54.2% | 3.41 |
| FY2019 | 50.8% | 2.93 |
| FY2018 | 47.9% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 55.7% | 0.27 |
| Jun 2026 | 55.4% | 2.86 |
| Mar 2026 | 52.5% | (2.16) |
| Dec 2025 | 54.7% | (2.36) |
| 24 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ADPT Adaptive Biotechnologies Corporation compare | 74.2% |
| VCYT Veracyte, Inc. compare | 72.0% |
| BLLN BillionToOne, Inc. compare | 71.4% |
| CDNA CareDx, Inc. compare | 71.0% |
| QGEN QIAGEN N.V. compare | 62.2% |
| SHC Sotera Health Company | 54.6% |
| NEO NeoGenomics, Inc. compare | 44.8% |
| RDNT RadNet, Inc. compare | 11.5% |
| GRAL GRAIL, Inc. compare | 0.00% |
| Diagnostics & Research industry median | 48.3% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on SHC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement